HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore
Adenoma

Adenomas are benign tumors that arise from glandular tissue. While typically non-cancerous, certain adenomas, particularly those in the colon, can progress to cancer if left untreated. Understanding the molecular mechanisms underlying this progression is crucial in cancer research. Researchers investigate genetic mutations and signaling pathways implicated in adenoma-to-carcinoma progression, aiming to identify biomarkers for early detection and targeted therapies. Advanced imaging techniques and molecular profiling help characterize adenomas and predict their malignant potential. Additionally, studying the tumor microenvironment provides insights into how adenomas interact with surrounding tissues, potentially influencing their transformation into cancer. By elucidating the complexities of adenoma biology, cancer researchers strive to develop more effective prevention and treatment strategies to reduce the burden of adenoma-associated cancers.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp